ANALYSIS OF THE MODERN ASSORTMENT OF MEDICINES USED TO TREAT INFLAMMATORY PERIODONTAL DISEASES

Abstract

Objective. Assortment analysis of dosage forms used to treat inflammatory periodontal diseases, taking into account active components, their pharmacological activity, as well as a share of domestic and foreign medicines.

Material and methods. Analysis of data from the information array «State Register of Medicines», the reference book of medicines «Vidal Online» and data from modern literature: Russian scientific electronic libraries eLIBRARY© and Cyberleninka©.

Results. Results of the work established the presence of 218 medicinal products of domestic and foreign manufacturers, approved for use in dental practice, produced in the form of liquid dosage forms (67.89%), soft dosage forms (7.34%), gaseous dosage forms (24.77%). Russian manufacturers account for 86.24% of medicinal products, foreign ones - 13.76%.

Conclusion. The study showed the dominant position of liquid dosage forms, distinguished by ease of use, rapid delivery of active substances to the site of inflammation. Soft dosage forms, despite their potential, make up only a small part of the market. A limited number of combination drugs combining antiseptic, anti-inflammatory, analgesic and regenerative properties were identified. A promising direction is the creation of gels based on natural biologically active compounds with a complex effect, which will increase the effectiveness of therapy and improve the quality of life of patients.